<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">BMC Cancer</journal-id>
      <journal-id journal-id-type="iso-abbrev">BMC Cancer</journal-id>
      <journal-title-group>
        <journal-title>BMC Cancer</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1471-2407</issn>
      <publisher>
        <publisher-name>BioMed Central</publisher-name>
        <publisher-loc>London</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">26036321</article-id>
      <article-id pub-id-type="pmc">4451732</article-id>
      <article-id pub-id-type="publisher-id">1467</article-id>
      <article-id pub-id-type="doi">10.1186/s12885-015-1467-7</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>The diagnostic challenge of pulmonary tumour thrombotic microangiopathy as a presentation for metastatic gastric cancer: a case report and review of the literature</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Ho</surname>
            <given-names>Andrew LK.</given-names>
          </name>
          <address>
            <email>andrewlkho@doctors.org.uk</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Szulakowsi</surname>
            <given-names>Patryk</given-names>
          </name>
          <address>
            <email>p.szulakowski@nhs.net</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Mohamid</surname>
            <given-names>Waria HS.</given-names>
          </name>
          <address>
            <email>waria.mohamid@nhs.net</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <aff id="Aff1">Lister Hospital, East and North Hertfordshire NHS Trust, Coreys Mill Lane, Stevenage Hertfordshire, SG1 4AB UK </aff>
      </contrib-group>
      <pub-date pub-type="epub">
        <day>3</day>
        <month>6</month>
        <year>2015</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>3</day>
        <month>6</month>
        <year>2015</year>
      </pub-date>
      <pub-date pub-type="collection">
        <year>2015</year>
      </pub-date>
      <volume>15</volume>
      <elocation-id>450</elocation-id>
      <history>
        <date date-type="received">
          <day>5</day>
          <month>2</month>
          <year>2015</year>
        </date>
        <date date-type="accepted">
          <day>22</day>
          <month>5</month>
          <year>2015</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; Ho et al.; licensee BioMed Central. 2015</copyright-statement>
        <license license-type="open-access">
          <license-p>This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0">http://creativecommons.org/licenses/by/4.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p>
        </license>
      </permissions>
      <abstract id="Abs1">
        <sec>
          <title>Background</title>
          <p>Pulmonary tumour thrombotic microangiopathy (PTTM) is a rare complication of metastatic cancer with a distinct histological appearance which presents with dyspnoea and pulmonary arterial hypertension and leads to death in hours to days. It is a challenging diagnosis to make ante mortem, in part due to the rapid clinical decline. Herein, we report a case of a young woman initially felt to have pulmonary sarcoidosis but who then died eight days later from what was found at post mortem to be PTTM.</p>
        </sec>
        <sec>
          <title>Case presentation</title>
          <p>A 41&#xA0;year old Caucasian woman presented with progressive dyspnoea. Computed tomography of her thorax showed diffuse tiny centrilobular nodules in a tree-in-bud appearance along with small volume mediastinal lymphadenopathy. A presumptive diagnosis of pulmonary sarcoidosis was made; bronchoscopy with transbronchial lung biopsy was arranged to confirm the diagnosis. However, she rapidly deteriorated and died eight days later. Post mortem examination revealed metastatic poorly differentiated gastric adenocarcinoma with PTTM being the final cause of death.</p>
        </sec>
        <sec>
          <title>Conclusion</title>
          <p>This case demonstrates the diagnostic difficulties in such a rare and rapidly fatal oncological complication; a greater awareness amongst clinicians may help make a positive diagnosis in the short window of time available. Little is known about its pathogenesis, and even less about optimal management strategies. We review the literature to demonstrate the clinical characteristics that might provide clues towards an ante mortem diagnosis, and highlight how imatinib may provide the key to treating PTTM.</p>
        </sec>
      </abstract>
      <kwd-group xml:lang="en">
        <title>Keywords</title>
        <kwd>Pulmonary tumour thrombotic microangiopathy</kwd>
        <kwd>Gastric adenocarcinoma</kwd>
        <kwd>Metastatic complications</kwd>
        <kwd>Progressive dyspnoea</kwd>
      </kwd-group>
      <custom-meta-group>
        <custom-meta>
          <meta-name>issue-copyright-statement</meta-name>
          <meta-value>&#xA9; The Author(s) 2015</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <sec id="Sec1" sec-type="introduction">
      <title>Background</title>
      <p>Pulmonary tumour thrombotic microangiopathy (PTTM) is a rare complication of cancer with a prevalence of 1.4&#xA0;% in one retrospective autopsy series of patients who died of cancer [<xref ref-type="bibr" rid="CR1">1</xref>]. Clinically, it is characterised by dyspnoea and pulmonary arterial hypertension, which almost invariably progresses to right heart strain and cardiorespiratory arrest in hours to days. Pathologically, there are widespread small tumour emboli; it is distinct from conventional tumour emboli in that there is fibrocellular intimal proliferation. The radiological findings on computed tomography are often of diffuse centrilobular nodular opacities, for which the differential diagnosis is wide.</p>
      <p>Herein, we report a case of a young woman who presented with dyspnoea and was initially felt to have pulmonary sarcoidosis. However, she rapidly deteriorated and died eight days later. This case report serves to highlight the diagnostic challenges involved in making a timely diagnosis of PTTM, and reviews the possible management options in this rare illness.</p>
      <sec id="Sec2">
        <title>Case presentation</title>
        <p>A 41&#xA0;year old Caucasian woman who was normally very active presented with progressive dyspnoea over the previous five months with an exercise tolerance deteriorating to twenty yards. She was a never-smoker and her past medical history only mentioned spinal fusion surgery in her thirties for congenital spinal scoliosis. Her only medication was Microgynon (a combined oral contraceptive pill). She denied any cough and was otherwise systemically well. A short course of oral steroids from her GP had temporarily improved her symptoms. Clinical examination was non-contributory; in particular, her chest was clear to auscultation and there was no peripherally palpable lymphadenopathy.</p>
        <p>Postero-anterior chest radiograph was unremarkable. Computed tomography pulmonary angiography (CTPA) was performed on suspicion of pulmonary embolism and she was given a single therapeutic dose of dalteparin. This demonstrated adequate opacification of the pulmonary arterial tree with no evidence of filling defect. There were diffuse tiny centrilobular soft tissue nodules forming a tree-in-bud appearance with their adjacent vessels, as well as small volume enlarged lymph nodes in the mediastinum (measuring 11&#xA0;mm in short axis diameter at the left hilum and adjacent to the aortic arch) (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1</xref>). The combination of lymphadenopathy and nodular infiltrates especially along the fissures and peripherally, in conjunction with the clinical presentation, led to a provisional diagnosis of sarcoidosis, although it was noted at the time that the differential diagnosis for this radiological picture is far wider.<fig id="Fig1"><label>Fig. 1</label><caption><p>Axial slice of CTPA performed during the patient&#x2019;s first admission. CTPA demonstrated small centrilobular soft tissue nodules with branching linear opacities forming a tree-in-bud appearance. This is most often caused by obstruction of small airways by, for example, mucus. In PTTM, however, it is caused by tumour cells in distal arterioles and the resultant inflammation that follows. The differential diagnosis for pulmonary nodular infiltrates with mediastinal lymphadenopathy, particularly the small volume adenopathy seen in our patient, is wide-ranging. It includes both malignant causes such as lymphoma as well as benign causes such as tuberculosis, inflammatory nodules, and sarcoidosis</p></caption><graphic xlink:href="12885_2015_1467_Fig1_HTML" id="MO1"/></fig></p>
        <p>An electrocardiogram showed fixed T wave inversion in leads III, aVF and V1. Transthoracic echocardiography showed a mildly dilated right ventricle (RV) with paradoxical motion of the RV septum indicating RV overload (although the estimated pulmonary artery pressures were not significantly elevated). Spirometry showed a normal FEV1 and FVC with an FEV1/FVC ratio of 73.4&#xA0;%; lung volumes and transfer factors were normal (table&#xA0;<xref rid="Tab1" ref-type="table">1</xref>). Adjusted calcium was within the normal range; serum angiotensin-converting enzyme levels were requested (later reported as normal at 26&#xA0;IU/l). She was discharged two days later with an appointment for an outpatient bronchoscopy with transbronchial lung biopsy.<table-wrap id="Tab1"><label>Table 1</label><caption><p>Pulmonary function tests</p></caption><table frame="hsides" rules="groups"><thead><tr><th colspan="3">Spirometry</th></tr></thead><tbody><tr><td>FEV1</td><td>2.47&#xA0;L</td><td>(80&#xA0;% predicted)</td></tr><tr><td>FVC</td><td>3.37&#xA0;L</td><td>(94&#xA0;% predicted)</td></tr><tr><td>FEV1/FVC</td><td>73.44&#xA0;%</td><td/></tr><tr><td colspan="3">Transfer factors</td></tr><tr><td>TLCO</td><td>70&#xA0;% predicted</td><td/></tr><tr><td>KCO</td><td>85&#xA0;% predicted</td><td/></tr><tr><td colspan="3">Body plethysmography</td></tr><tr><td>TLC</td><td>5.24&#xA0;L</td><td>(97&#xA0;% predicted)</td></tr><tr><td>VC</td><td>3.39&#xA0;L</td><td>(93&#xA0;% predicted)</td></tr></tbody></table><table-wrap-foot><p>Pulmonary function tests performed seven days ante mortem, including lung volumes and transfer factors, were unremarkable</p></table-wrap-foot></table-wrap></p>
        <p>She re-presented three days later feeling generally unwell with worsening dyspnoea, nausea, loss of appetite and diffuse headache. She was now tachycardic (100&#xA0;bpm), tachypnoeic (24/min) and hypoxic (SpO<sub>2</sub> 93&#xA0;% on air). Clinical examination was once again non-contributory. Arterial blood gas analysis showed type 1 respiratory failure (PaO<sub>2</sub> 8.18 kPa with FiO<sub>2</sub> 21&#xA0;%). Electrocardiography showed progression of the right ventricular strain pattern with T wave inversion now in leads III, aVF, and V1&#x2013;4.</p>
        <p>She was noted to have an isolated thrombocytopaenia (93 x10<sup>9</sup>/L); there was no clinical or laboratory evidence of a hypercoagulable state. She was supported with oxygen (up to 4&#xA0;L/min via nasal cannulae) and also started on co-amoxiclav and clarithromycin as she had a mild neutrophilia (13.17 x10<sup>9</sup>/L with C-reactive protein (CRP) 73&#xA0;mg/l) to cover for an infective cause for her deterioration. Bronchoscopy with transbronchial lung biopsy, previously intended to be an outpatient investigation, was organised as an inpatient to confirm the diagnosis of pulmonary sarcoidosis. Corticosteroid therapy was not initiated in order to maximise the diagnostic yield of lung biopsy.</p>
        <p>Two days after her readmission, whilst awaiting bronchoscopy, she developed persistent tachycardia (100&#x2013;130&#xA0;bpm) and tachypnoea (22&#x2013;30/min) but with normal blood pressure and stable peripheral oxygen saturations on 2&#x2013;4&#xA0;L/min oxygen. She was noted to have an episode of unresponsiveness similar to an absence seizure lasting twenty seconds, followed by around thirty seconds of abnormal posturing (flexion but no jerking of limbs) and urinary incontinence. Magnetic resonance imaging of her head was performed to exclude neurosarcoidosis; this was normal. Later the following day, eight days since her first presentation, she suddenly deteriorated over a few minutes and went into cardio-respiratory arrest with pulseless electrical activity (PEA)/asystole. Despite a prolonged resuscitation attempt she passed away.</p>
        <p>Post mortem examination revealed widespread tumour emboli with associated thromboemboli in the subsegmental branches of the pulmonary arterial tree; microscopically, the appearances were consistent with a diagnosis of pulmonary tumour thrombotic microangiopathy. The antecedent cause for this was poorly differentiated adenocarcinoma with signet ring cells in the anterior wall of the stomach (Figs.&#xA0;<xref rid="Fig2" ref-type="fig">2</xref> and <xref rid="Fig3" ref-type="fig">3</xref>). Miliary metastases were found in the lung parenchyma as well as metastatic deposits in the kidneys and bone marrow. Sections taken from the brain showed no evidence of occlusive thrombosis or thromboemboli within the intracranial blood vessels; the cause for the neurological event which the patient experienced remains unknown. Retrospective review of the history did not reveal any symptoms indicative of dyspepsia, gastric malignancy, or (other than several weeks of general malaise) occult malignant disease.<fig id="Fig2"><label>Fig. 2</label><caption><p>Histological findings of the stomach wall at post mortem. Haematoxylin and eosin (H&amp;E)-stained sections of the anterior gastric wall showed adenocarcinoma with signet ring cell forms</p></caption><graphic xlink:href="12885_2015_1467_Fig2_HTML" id="MO2"/></fig><fig id="Fig3"><label>Fig. 3</label><caption><p>Histological findings of pulmonary vasculature at post mortem. Post mortem examination of the sections taken from both lungs revealed widespread tumour emboli in small and medium sized arterial vessels including sub-segmental branches of the pulmonary arterial tree. This finding was associated with florid intimal fibrocellular proliferation and muscular hyperplasia of the pulmonary vasculature leading to luminal narrowing and stenosis with extensive intra-luminal thrombosis. The pathological conclusion of PTTM is substantiated by the clinical history of the patient's presentation and clinical outcome of the case</p></caption><graphic xlink:href="12885_2015_1467_Fig3_HTML" id="MO3"/></fig></p>
      </sec>
    </sec>
    <sec id="Sec3" sec-type="discussion">
      <title>Discussion</title>
      <p>PTTM is a rare clinico-pathological entity first described by von Herbay <italic>et al.</italic> in 1990. It is a complication of cancer characterised by widespread microscopic (usually non-occlusive) tumour emboli in the pulmonary arterioles. The distinction from conventional tumour emboli is that it features localised activation of coagulation pathways and the resultant histopathological finding of fibrocellular intimal proliferation with or without secondary thrombosis [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR3">3</xref>].</p>
      <p>For reasons that are not known, the clear majority of cases of PTTM arise from gastric adenocarcinomas, often those of the signet ring cell subtype. In reviewing all cases published in PubMed-indexed journals, we found that gastric cancer accounts for around 60&#xA0;% of cases, with the remainder comprising lung cancer (9&#xA0;%), cancer of unknown primary (6&#xA0;%), breast cancer (3&#xA0;%), and a few rarely-reported tumour sites.</p>
      <p>The clinical presentation is typically of acute dyspnoea. There is a very rapid clinical course, progressing to death in a matter of hours to days. Echocardiography, if performed in a timely fashion, may show features of pulmonary hypertension and right heart strain (with raised pulmonary arterial pressure on right heart catheterisation) [<xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR5">5</xref>]. The picture of rapidly progressive dyspnoea often prompts the team managing the patient to organise a CT scan of the thorax. If angiography is performed at the same time, it is usually negative for acute pulmonary embolism [<xref ref-type="bibr" rid="CR1">1</xref>]. Instead, there are diffuse centrilobular nodular opacities in a tree-in-bud pattern throughout the lung fields, with the possible additional signs of acute cor pulmonale [<xref ref-type="bibr" rid="CR6">6</xref>&#x2013;<xref ref-type="bibr" rid="CR8">8</xref>].</p>
      <p>A number of proteins have been implicated as mediators in the development of PTTM. Vascular endothelial growth factor [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR9">9</xref>] and tissue factor [<xref ref-type="bibr" rid="CR10">10</xref>] are expressed more frequently in cancer cells leading to PTTM than those with traditional tumour emboli. Platelet-derived growth factor (PDGF) is also expressed more frequently in PTTM-associated cancer cells [<xref ref-type="bibr" rid="CR9">9</xref>], although the association may be more complex with PDGF overexpression also present in alveolar macrophages and PDGF receptor expression in the proliferating fibromuscular intimal cells [<xref ref-type="bibr" rid="CR11">11</xref>]. Osteopontin has also been implicated [<xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR13">13</xref>]. However, demonstrating overexpression of these factors falls short to construct a model for the pathogenesis of PTTM which remains to be elucidated.</p>
      <p>As in our case, PTTM may well occur in patients hitherto unknown to be harbouring malignant disease. The combination of acute dyspnoea as the initial presentation for metastatic disease combined with a rapid deterioration makes ante mortem diagnosis a significant challenge [<xref ref-type="bibr" rid="CR14">14</xref>]. Indeed, there are only ten case reports in the literature where the diagnosis of PTTM was made whilst the patient was still alive: five were diagnosed by transbronchial lung biopsy [<xref ref-type="bibr" rid="CR15">15</xref>&#x2013;<xref ref-type="bibr" rid="CR19">19</xref>], two by video-assisted thoracoscopic surgery [<xref ref-type="bibr" rid="CR20">20</xref>, <xref ref-type="bibr" rid="CR21">21</xref>], one by CT-guided biopsy [<xref ref-type="bibr" rid="CR22">22</xref>]; the final two were presumptive ante mortem diagnoses based on proven pulmonary hypertension and the finding of tumour cells from wedged pulmonary artery catheter aspiration [<xref ref-type="bibr" rid="CR23">23</xref>, <xref ref-type="bibr" rid="CR24">24</xref>].</p>
      <p>Early ante mortem diagnosis is, however, only the first step towards successful treatment. To date, there are only four case reports in the literature of patients who survived beyond the initial acute phase. The first was in 2007 when a patient with VATS biopsy-proven PTTM from gastric adenocarcinoma was treated with dexamethasone, warfarin, aspirin and fluoropyrimidine-based chemotherapy. The patient's symptoms and radiographic findings resolved, and she was well at six month follow-up [<xref ref-type="bibr" rid="CR20">20</xref>].</p>
      <p>The remaining three cases all experienced significant improvement following the administration of imatinib alongside other medications such as prostacyclin analogs and endothelial receptor antagonists to manage their pulmonary hypertension. These patients had improved pulmonary hypertension but died of either progressive disease [<xref ref-type="bibr" rid="CR18">18</xref>, <xref ref-type="bibr" rid="CR23">23</xref>] or, in one case, influenza infection [<xref ref-type="bibr" rid="CR24">24</xref>]. There are reports of imatinib being useful in pulmonary arterial hypertension in the non-PTTM setting [<xref ref-type="bibr" rid="CR25">25</xref>], although its use is currently confined to clinical trials due to the IMPRES study which showed increased morbidity from adverse events despite an improvement in haemodynamics [<xref ref-type="bibr" rid="CR26">26</xref>]. That imatinib appears to alter the natural history of PTTM lends credence to the theory that PDGF is involved in the pathophysiology. Disappointingly, although PDGF levels fell following imatinib therapy, Ogawa <italic>et al.</italic> did not actually find PDGF expression in either tumour cells or intimal cells. They hypothesised that this was because the biopsy specimen was taken after administration of imatinib and subsequent clinical improvement [<xref ref-type="bibr" rid="CR18">18</xref>].</p>
      <p>An earlier diagnosis (such as on her first hospital admission) is unlikely to have changed the prognosis in this lady with widespread carcinoma, but it should be remembered that definitive diagnosis is not purely an academic pursuit in terminal conditions. There is evidence to suggest that the act of providing information to cancer patients can reduce anxiety [<xref ref-type="bibr" rid="CR27">27</xref>]. Knowledge of their illness is valuable in that it allows patients to contextualise life decisions [<xref ref-type="bibr" rid="CR28">28</xref>, <xref ref-type="bibr" rid="CR29">29</xref>].</p>
    </sec>
    <sec id="Sec4" sec-type="conclusion">
      <title>Conclusions</title>
      <p>This case shows the challenges of diagnosing and managing PTTM. This is particularly true for three reasons: the relatively non-specific symptom of dyspnoea; the fact that the patient often does not have a known malignancy; and the rate of clinical decline leading almost inevitably to death. Clinicians should be aware of this as a diagnostic entity, aided by the radiographic findings outlined above as well as the developement of rapidly progressive pulmonary arterial hypertension. More research into the pathogenesis of this condition is clearly required, but given the cases outlined above it seems reasonable that a trial of imatinib should form part of the treatment strategy.</p>
      <sec id="Sec5">
        <title>Consent</title>
        <p>Written informed consent was obtained from the next of kin for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor of this journal.</p>
      </sec>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn>
        <p>An erratum to this article is available at <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1186/s12885-015-1601-6">http://dx.doi.org/10.1186/s12885-015-1601-6</ext-link>.</p>
      </fn>
      <fn>
        <p>
          <bold>Competing interests</bold>
        </p>
        <p>The authors declare that they have no competing interests.</p>
      </fn>
      <fn>
        <p>
          <bold>Authors&#x2019; contributions</bold>
        </p>
        <p>ALKH and PS were involved in the clinical management of the patient. WHS performed the post mortem examination and prepared the slides. ALKH wrote and edited the manuscript. All authors read and approved the final manuscript.</p>
      </fn>
    </fn-group>
    <ack>
      <title>Acknowledgements</title>
      <p>The authors would like to extend their gratitude to the patient&#x2019;s family for giving consent, and also to Sue Buckingham (Consultant Radiologist) for her assistance in preparing the radiological images for publication.</p>
    </ack>
    <ref-list id="Bib1">
      <title>References</title>
      <ref id="CR1">
        <label>1.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Uruga</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Fujii</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Kurosaki</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Hanada</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Takaya</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Miyamoto</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Pulmonary tumor thrombotic microangiopathy: a clinical analysis of 30 autopsy cases</article-title>
          <source>Intern Med</source>
          <year>2013</year>
          <volume>52</volume>
          <issue>12</issue>
          <fpage>1317</fpage>
          <lpage>23</lpage>
          <pub-id pub-id-type="doi">10.2169/internalmedicine.52.9472</pub-id>
          <pub-id pub-id-type="pmid">23774540</pub-id>
        </element-citation>
      </ref>
      <ref id="CR2">
        <label>2.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>von Herbay</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Illes</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Waldherr</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Otto</surname>
              <given-names>HF</given-names>
            </name>
          </person-group>
          <article-title>Pulmonary tumor thrombotic microangiopathy with pulmonary hypertension</article-title>
          <source>Cancer</source>
          <year>1990</year>
          <volume>66</volume>
          <issue>3</issue>
          <fpage>587</fpage>
          <lpage>92</lpage>
          <pub-id pub-id-type="doi">10.1002/1097-0142(19900801)66:3&lt;587::AID-CNCR2820660330&gt;3.0.CO;2-J</pub-id>
          <pub-id pub-id-type="pmid">2163747</pub-id>
        </element-citation>
      </ref>
      <ref id="CR3">
        <label>3.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sato</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Marutsuka</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Asada</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Yamada</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Setoguchi</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Sumiyoshi</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Pulmonary tumor thrombotic microangiopathy</article-title>
          <source>Pathol Int</source>
          <year>1995</year>
          <volume>45</volume>
          <issue>6</issue>
          <fpage>436</fpage>
          <lpage>40</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1440-1827.1995.tb03481.x</pub-id>
          <pub-id pub-id-type="pmid">7581935</pub-id>
        </element-citation>
      </ref>
      <ref id="CR4">
        <label>4.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shih</surname>
              <given-names>H-M</given-names>
            </name>
            <name>
              <surname>Lin</surname>
              <given-names>C-C</given-names>
            </name>
            <name>
              <surname>Shiao</surname>
              <given-names>Y-W</given-names>
            </name>
          </person-group>
          <article-title>Pulmonary tumor thrombotic microangiopathy</article-title>
          <source>Am J Emerg Med</source>
          <year>2011</year>
          <volume>29</volume>
          <issue>2</issue>
          <fpage>241.e3</fpage>
          <lpage>4</lpage>
          <pub-id pub-id-type="doi">10.1016/j.ajem.2010.03.004</pub-id>
          <pub-id pub-id-type="pmid">20825897</pub-id>
        </element-citation>
      </ref>
      <ref id="CR5">
        <label>5.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Keenan</surname>
              <given-names>NG</given-names>
            </name>
            <name>
              <surname>Nicholson</surname>
              <given-names>AG</given-names>
            </name>
            <name>
              <surname>Oldershaw</surname>
              <given-names>PJ</given-names>
            </name>
          </person-group>
          <article-title>Fatal acute pulmonary hypertension caused by pulmonary tumour thrombotic microangiopathy</article-title>
          <source>Int J Cardiol</source>
          <year>2008</year>
          <volume>124</volume>
          <issue>1</issue>
          <fpage>e11</fpage>
          <lpage>3</lpage>
          <pub-id pub-id-type="doi">10.1016/j.ijcard.2006.11.162</pub-id>
          <pub-id pub-id-type="pmid">17349704</pub-id>
        </element-citation>
      </ref>
      <ref id="CR6">
        <label>6.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kuwabara</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Yoshida</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Takasu</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Yuki</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Goto</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Hanafusa</surname>
              <given-names>T</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Pulmonary tumor thrombotic microangiopathy caused by gastric cancer</article-title>
          <source>Ann Thorac Med</source>
          <year>2012</year>
          <volume>7</volume>
          <issue>3</issue>
          <fpage>168</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="doi">10.4103/1817-1737.98853</pub-id>
          <pub-id pub-id-type="pmid">22924078</pub-id>
        </element-citation>
      </ref>
      <ref id="CR7">
        <label>7.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Franquet</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Gim&#xE9;nez</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Prats</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Rodr&#xED;guez-Arias</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Rodr&#xED;guez</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>Thrombotic microangiopathy of pulmonary tumors: a vascular cause of tree-in-bud pattern on CT</article-title>
          <source>AJR Am J Roentgenol</source>
          <year>2002</year>
          <volume>179</volume>
          <issue>4</issue>
          <fpage>897</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="doi">10.2214/ajr.179.4.1790897</pub-id>
          <pub-id pub-id-type="pmid">12239033</pub-id>
        </element-citation>
      </ref>
      <ref id="CR8">
        <label>8.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Guimar&#xE3;es</surname>
              <given-names>MD</given-names>
            </name>
            <name>
              <surname>Almeida</surname>
              <given-names>MFA</given-names>
            </name>
            <name>
              <surname>Brelinger</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Barbosa</surname>
              <given-names>PN</given-names>
            </name>
            <name>
              <surname>Chojniak</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Gross</surname>
              <given-names>JL</given-names>
            </name>
          </person-group>
          <article-title>Diffuse bronchiolitis pattern on a computed tomography scan as a presentation of pulmonary tumor thrombotic microangiopathy: a case report</article-title>
          <source>J Med Case Rep</source>
          <year>2011</year>
          <volume>5</volume>
          <fpage>575</fpage>
          <pub-id pub-id-type="doi">10.1186/1752-1947-5-575</pub-id>
          <pub-id pub-id-type="pmid">22151903</pub-id>
        </element-citation>
      </ref>
      <ref id="CR9">
        <label>9.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Abe</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Hino</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Fukayama</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Platelet-derived growth factor-A and vascular endothelial growth factor-C contribute to the development of pulmonary tumor thrombotic microangiopathy in gastric cancer</article-title>
          <source>Virchows Arch</source>
          <year>2013</year>
          <volume>462</volume>
          <issue>5</issue>
          <fpage>523</fpage>
          <lpage>31</lpage>
          <pub-id pub-id-type="doi">10.1007/s00428-013-1403-7</pub-id>
          <pub-id pub-id-type="pmid">23536282</pub-id>
        </element-citation>
      </ref>
      <ref id="CR10">
        <label>10.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Okubo</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Wakayama</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Kitahara</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Nemoto</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Yokose</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Abe</surname>
              <given-names>F</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Pulmonary tumor thrombotic microangiopathy induced by gastric carcinoma: morphometric and immunohistochemical analysis of six autopsy cases</article-title>
          <source>Diagn Pathol</source>
          <year>2011</year>
          <volume>6</volume>
          <issue>1</issue>
          <fpage>27</fpage>
          <pub-id pub-id-type="doi">10.1186/1746-1596-6-27</pub-id>
          <pub-id pub-id-type="pmid">21450103</pub-id>
        </element-citation>
      </ref>
      <ref id="CR11">
        <label>11.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yokomine</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Hirakawa</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Ozawa</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Shibata</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Nakayama</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Pulmonary thrombotic microangiopathy caused by gastric carcinoma</article-title>
          <source>J Clin Pathol</source>
          <year>2010</year>
          <volume>63</volume>
          <issue>4</issue>
          <fpage>367</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="doi">10.1136/jcp.2010.075739</pub-id>
          <pub-id pub-id-type="pmid">20354211</pub-id>
        </element-citation>
      </ref>
      <ref id="CR12">
        <label>12.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hotta</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Ishida</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Kojima</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Iwai</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Okabe</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>Pulmonary tumor thrombotic microangiopathy caused by lung adenocarcinoma: Case report with review of the literature</article-title>
          <source>Oncol Lett</source>
          <year>2011</year>
          <volume>2</volume>
          <issue>3</issue>
          <fpage>435</fpage>
          <lpage>7</lpage>
          <pub-id pub-id-type="pmid">22866100</pub-id>
        </element-citation>
      </ref>
      <ref id="CR13">
        <label>13.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Takahashi</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Kumasaka</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Nagaoka</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Wakiya</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Fujii</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Shimizu</surname>
              <given-names>K</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Osteopontin expression in pulmonary tumor thrombotic microangiopathy caused by gastric carcinoma</article-title>
          <source>Pathol Int</source>
          <year>2009</year>
          <volume>59</volume>
          <issue>10</issue>
          <fpage>752</fpage>
          <lpage>6</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1440-1827.2009.02439.x</pub-id>
          <pub-id pub-id-type="pmid">19788622</pub-id>
        </element-citation>
      </ref>
      <ref id="CR14">
        <label>14.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Patrignani</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Purcaro</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Calcagnoli</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Mandolesi</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Bearzi</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Ciampani</surname>
              <given-names>N</given-names>
            </name>
          </person-group>
          <article-title>Pulmonary tumor thrombotic microangiopathy: the challenge of the antemortem diagnosis</article-title>
          <source>J Cardiovasc Med (Hagerstown)</source>
          <year>2014</year>
          <volume>15</volume>
          <issue>11</issue>
          <fpage>828</fpage>
          <lpage>33</lpage>
          <pub-id pub-id-type="doi">10.2459/JCM.0b013e328354e473</pub-id>
          <pub-id pub-id-type="pmid">22710763</pub-id>
        </element-citation>
      </ref>
      <ref id="CR15">
        <label>15.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Noguchi</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Imanaga</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Shimizu</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Nakano</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Miyazaki</surname>
              <given-names>N</given-names>
            </name>
          </person-group>
          <article-title>[Case of pulmonary tumor thrombotic microangiopathy diagnosed by transbronchial lung biopsy]</article-title>
          <source>Nihon Kokyuki Gakkai Zasshi</source>
          <year>2008</year>
          <volume>46</volume>
          <issue>6</issue>
          <fpage>493</fpage>
          <lpage>6</lpage>
          <pub-id pub-id-type="pmid">18592997</pub-id>
        </element-citation>
      </ref>
      <ref id="CR16">
        <label>16.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ishiguro</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Takayanagi</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Ando</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Yanagisawa</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Shimizu</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Sugita</surname>
              <given-names>Y</given-names>
            </name>
          </person-group>
          <article-title>[Pulmonary tumor thrombotic microangiopathy responding to chemotherapy]</article-title>
          <source>Nihon Kokyuki Gakkai Zasshi</source>
          <year>2011</year>
          <volume>49</volume>
          <issue>9</issue>
          <fpage>681</fpage>
          <lpage>7</lpage>
          <pub-id pub-id-type="pmid">22073615</pub-id>
        </element-citation>
      </ref>
      <ref id="CR17">
        <label>17.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ueda</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Fuse</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Fujii</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Sasaki</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Sugiyama</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Kojima</surname>
              <given-names>T</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Pulmonary tumor thrombotic microangiopathy associated with esophageal squamous cell carcinoma</article-title>
          <source>Intern Med</source>
          <year>2011</year>
          <volume>50</volume>
          <issue>22</issue>
          <fpage>2807</fpage>
          <lpage>10</lpage>
          <pub-id pub-id-type="doi">10.2169/internalmedicine.50.6113</pub-id>
          <pub-id pub-id-type="pmid">22082893</pub-id>
        </element-citation>
      </ref>
      <ref id="CR18">
        <label>18.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ogawa</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Yamadori</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Matsubara</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Matsubara</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>Pulmonary tumor thrombotic microangiopathy with circulatory failure treated with imatinib</article-title>
          <source>Intern Med</source>
          <year>2013</year>
          <volume>52</volume>
          <issue>17</issue>
          <fpage>1927</fpage>
          <lpage>30</lpage>
          <pub-id pub-id-type="doi">10.2169/internalmedicine.52.0718</pub-id>
          <pub-id pub-id-type="pmid">23994985</pub-id>
        </element-citation>
      </ref>
      <ref id="CR19">
        <label>19.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kitamura</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Nishimura</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Jinta</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Suda</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Yamano</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Ishikawa</surname>
              <given-names>G</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>A case of pulmonary tumor thrombotic microangiopathy diagnosed by transbronchial lung biopsy and treated with chemotherapy and long-term oxygen and anticoagulation therapies</article-title>
          <source>Case Rep Pulmonol</source>
          <year>2013</year>
          <volume>2013</volume>
          <fpage>259080</fpage>
          <pub-id pub-id-type="pmid">24069542</pub-id>
        </element-citation>
      </ref>
      <ref id="CR20">
        <label>20.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Miyano</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Izumi</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Takeda</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Tokuhara</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Mochizuki</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Matsubara</surname>
              <given-names>O</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Pulmonary tumor thrombotic microangiopathy</article-title>
          <source>J Clin Oncol</source>
          <year>2007</year>
          <volume>25</volume>
          <issue>5</issue>
          <fpage>597</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="doi">10.1200/JCO.2006.09.0670</pub-id>
          <pub-id pub-id-type="pmid">17290069</pub-id>
        </element-citation>
      </ref>
      <ref id="CR21">
        <label>21.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kayatani</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Matsuo</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Ueda</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Matsushita</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Fujiwara</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Yonei</surname>
              <given-names>T</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Pulmonary tumor thrombotic microangiopathy diagnosed antemortem and treated with combination chemotherapy</article-title>
          <source>Intern Med</source>
          <year>2012</year>
          <volume>51</volume>
          <issue>19</issue>
          <fpage>2767</fpage>
          <lpage>70</lpage>
          <pub-id pub-id-type="doi">10.2169/internalmedicine.51.7682</pub-id>
          <pub-id pub-id-type="pmid">23037471</pub-id>
        </element-citation>
      </ref>
      <ref id="CR22">
        <label>22.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Uruga</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Morokawa</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Enomoto</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Takaya</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Miyamoto</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Kishi</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>[A case of pulmonary tumor thrombotic microangiopathy associated with lung adenocarcinoma diagnosed by CT-guided lung biopsy]</article-title>
          <source>Nihon Kokyuki Gakkai Zasshi</source>
          <year>2008</year>
          <volume>46</volume>
          <issue>11</issue>
          <fpage>928</fpage>
          <lpage>33</lpage>
          <pub-id pub-id-type="pmid">19068768</pub-id>
        </element-citation>
      </ref>
      <ref id="CR23">
        <label>23.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fukada</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Araki</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Minatsuki</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Fujino</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Hatano</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Numakura</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Imatinib Alleviated Pulmonary Hypertension Caused by Pulmonary Tumor Thrombotic Microangiopathy in a Patient With Metastatic Breast Cancer</article-title>
          <source>Clin Breast Cancer</source>
          <year>2015</year>
          <volume>15</volume>
          <issue>2</issue>
          <fpage>e167</fpage>
          <lpage>70</lpage>
          <pub-id pub-id-type="doi">10.1016/j.clbc.2014.10.008</pub-id>
          <pub-id pub-id-type="pmid">25468406</pub-id>
        </element-citation>
      </ref>
      <ref id="CR24">
        <label>24.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Higo</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Kubota</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Takeda</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Higashi</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Ohishi</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Successful antemortem diagnosis and treatment of pulmonary tumor thrombotic microangiopathy</article-title>
          <source>Intern Med</source>
          <year>2014</year>
          <volume>53</volume>
          <issue>22</issue>
          <fpage>2595</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="doi">10.2169/internalmedicine.53.2379</pub-id>
          <pub-id pub-id-type="pmid">25400181</pub-id>
        </element-citation>
      </ref>
      <ref id="CR25">
        <label>25.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ghofrani</surname>
              <given-names>HA</given-names>
            </name>
            <name>
              <surname>Seeger</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Grimminger</surname>
              <given-names>F</given-names>
            </name>
          </person-group>
          <article-title>Imatinib for the treatment of pulmonary arterial hypertension</article-title>
          <source>N Engl J Med</source>
          <year>2005</year>
          <volume>353</volume>
          <issue>13</issue>
          <fpage>1412</fpage>
          <lpage>3</lpage>
          <pub-id pub-id-type="doi">10.1056/NEJMc051946</pub-id>
          <pub-id pub-id-type="pmid">16192491</pub-id>
        </element-citation>
      </ref>
      <ref id="CR26">
        <label>26.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Crosswhite</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Sun</surname>
              <given-names>Z</given-names>
            </name>
          </person-group>
          <article-title>Molecular mechanisms of pulmonary arterial remodeling</article-title>
          <source>Mol Med</source>
          <year>2014</year>
          <volume>20</volume>
          <fpage>191</fpage>
          <lpage>201</lpage>
          <pub-id pub-id-type="doi">10.2119/molmed.2013.00165</pub-id>
          <pub-id pub-id-type="pmid">24676136</pub-id>
        </element-citation>
      </ref>
      <ref id="CR27">
        <label>27.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fallowfield</surname>
              <given-names>LJ</given-names>
            </name>
            <name>
              <surname>Hall</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Maguire</surname>
              <given-names>GP</given-names>
            </name>
            <name>
              <surname>Baum</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Psychological outcomes of different treatment policies in women with early breast cancer outside a clinical trial</article-title>
          <source>BMJ</source>
          <year>1990</year>
          <volume>301</volume>
          <issue>6752</issue>
          <fpage>575</fpage>
          <lpage>80</lpage>
          <pub-id pub-id-type="doi">10.1136/bmj.301.6752.575</pub-id>
          <pub-id pub-id-type="pmid">2242455</pub-id>
        </element-citation>
      </ref>
      <ref id="CR28">
        <label>28.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Smith</surname>
              <given-names>AK</given-names>
            </name>
            <name>
              <surname>Williams</surname>
              <given-names>BA</given-names>
            </name>
            <name>
              <surname>Lo</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <article-title>Discussing overall prognosis with the very elderly</article-title>
          <source>N Engl J Med</source>
          <year>2011</year>
          <volume>365</volume>
          <issue>23</issue>
          <fpage>2149</fpage>
          <lpage>51</lpage>
          <pub-id pub-id-type="doi">10.1056/NEJMp1109990</pub-id>
          <pub-id pub-id-type="pmid">22150033</pub-id>
        </element-citation>
      </ref>
      <ref id="CR29">
        <label>29.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Steinhauser</surname>
              <given-names>KE</given-names>
            </name>
            <name>
              <surname>Christakis</surname>
              <given-names>NA</given-names>
            </name>
            <name>
              <surname>Clipp</surname>
              <given-names>EC</given-names>
            </name>
            <name>
              <surname>McNeilly</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Grambow</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Parker</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Preparing for the end of life: preferences of patients, families, physicians, and other care providers</article-title>
          <source>J Pain Symptom Manage</source>
          <year>2001</year>
          <volume>22(</volume>
          <issue>3</issue>
          <fpage>727</fpage>
          <lpage>37</lpage>
          <pub-id pub-id-type="doi">10.1016/S0885-3924(01)00334-7</pub-id>
          <pub-id pub-id-type="pmid">11532586</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
